Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
Abstract Immune deficits after CD19 chimeric antigen receptor (CAR) T‐cell therapy can be long‐lasting, predisposing patients to infections and non‐relapse mortality. In B‐cell non‐Hodgkin lymphoma (B‐NHL), the prognostic impact of immune reconstitution (IR) remains ill‐defined, and detailed cross‐p...
Saved in:
| Main Authors: | Sophia Stock, Veit L. Bücklein, Viktoria Blumenberg, Giulia Magno, Alica‐Joana Emhardt, Alessandra M. E. Holzem, David M. Cordas dos Santos, Christian Schmidt, Stefanie Grießhammer, Lisa Frölich, Sebastian Kobold, Michael vonBergwelt‐Baildon, Kai Rejeski, Marion Subklewe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70062 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
11th Immunotherapy of Cancer conference (ITOC): A meeting report
by: Stefanos Michaelides, et al.
Published: (2025-12-01) -
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.
by: Andreas Draube, et al.
Published: (2011-04-01) -
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups
by: Ricarda Knabe, et al.
Published: (2025-07-01) -
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients
by: Raed Alroughani, et al.
Published: (2025-05-01) -
Reconstitution of circadian clock in synthetic cells reveals principles of timekeeping
by: Alexander Zhan Tu Li, et al.
Published: (2025-07-01)